The report will be delivered in 2-3 business days.

Thyroid Cancer Drugs Global Market Report 2019

Starting Price : $ 4000.00 | Pages : 200 | Published : December 2019 | SKU CODE : 7229 | Format :


The thyroid cancer drugs market consists of sales of drugs that are used to treat thyroid cancer. The thyroid tissue is made up of follicular cells and parafollicular cells in which cancer develops. The types of thyroid cancer include follicular, papillary, medullary, anaplastic and thyroid lymphoma.

The global thyroid cancer drugs market was valued at about $0.4 billion in 2018 and is expected to grow to $0.77 billion at a CAGR of 17.7% through 2022.

North America was the largest region in the thyroid cancer drugs market in 2018, followed by Europe. The thyroid cancer drugs market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.

Increasing incidences of thyroid cancer, especially in women is driving the thyroid cancer drugs market. According to the American Cancer Society, women are three times more likely to develop thyroid cancer than men. Thyroid cancer is rising at a fast pace and it is estimated that 52,070 new cases of thyroid cancer will be found in the USA in 2019 and an estimated 2,170 deaths will occur because of the disease. The increase in thyroid cancer can be attributed to exposure to radiation, family history of goiter and some hereditary syndromes. 

Increasing use of targeted therapies for the treatment of thyroid cancer is acting as a restraint on the thyroid cancer drugs market. Targeted therapies target cancer specific genes, proteins and tissues that promote cancer growth and survival. Targeted therapies are increasingly being used to treat thyroid cancer as thyroid hormone-based treatments including radioactive iodine therapy are not effective against these cancers. For example, Vandetanib (Caprelsa) and Cabozantinib (Cometriq) are targeted therapies used to treat advanced medullary thyroid cancer (MTC). As patients increasingly use targeted therapies for treatment, demand for thyroid cancer drugs is decreasing, affecting market growth.

Combination drugs are increasingly being used in the treatment of thyroid cancer as they are more effective and help prevent cancer progression. A combination drug includes two or more active pharmaceutical ingredients (APIs) combined in a single dosage form. These drugs reduce the development of drug resistance and prevent the growth of cancer cells. For instance, in 2018, the FDA approved the combination of dabrafenib (Tafinlar), a BRAF inhibitor, and trametinib (Mekinist), a MEK inhibitor for the treatment of anaplastic thyroid cancer.

Manufacturers of thyroid cancer drugs are governed by regulatory authorities such as the Food and Drug Administration in the USA. For instance, off-label usage of FDA approved drugs for the treatment of cancer requires approval from the FDA. Manufacturers are required to submit a supplemental marketing application called sNDA( Supplemental New Drug Application) to the FDA that approves the drug for prescription.

In February 2019, Eli Lilly and Company acquired Loxo Oncology, Inc.for $8 Billion. The acquisition provides Eli Lilly access to a pipeline of investigational medicines like RET inhibitors which are used in thyroid cancer treatment. Loxo Oncology was established in 2013 and is located in Stamford, USA.

Major players in the market are Mylan Pharmaceuticals Inc., Alara Pharmaceutical Corporation, Bristol Myers co., Teva parenteral medicines Inc., Jerome Stevens Pharmaceuticals Inc.

    1. Executive Summary

    2. Thyroid Cancer Drugs Market Characteristics

    3. Thyroid Cancer Drugs Market Size And Growth

    3.1. Global Thyroid Cancer Drugs Historic Market, 2014 - 2018, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Thyroid Cancer Drugs Forecast Market, 2018 - 2022F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Thyroid Cancer Drugs Market Segmentation

    4.1. Global Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Ipilimumab

    Cabozantinib-S-Malate

    Caprelsa (Vandetanib)

    Doxorubicin Hydrochloride

    Lenvatinib Mesylate

    Nivolumab

    Vandetanib

    Others

    4.2. Global Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Hospitals

    Oncology Clinics

    Research Organizations

    Others

    4.3. Global Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Radioiodine Ablation

    Thyroid Stimulating Hormone (THS) Suppression

    Chemotherapy

    Targeted Multikinase Therapy

    Others

    5. Thyroid Cancer Drugs Market Regional And Country Analysis

    5.1. Global Thyroid Cancer Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    5.2. Global Thyroid Cancer Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Thyroid Cancer Drugs Market  

    6.1. Asia-Pacific Thyroid Cancer Drugs Market Overview  

    6.2. Asia-Pacific Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6.3. Asia-Pacific Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6.4. Asia-Pacific Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    7. China Thyroid Cancer Drugs Market  

    7.1. China Thyroid Cancer Drugs Market Overview  

    7.2. China Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    7.3. China Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    7.4. China Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    8. India Thyroid Cancer Drugs Market  

    8.1. India Thyroid Cancer Drugs Market Overview  

    8.2. India Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    8.3. India Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    8.4. India Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9. Japan Thyroid Cancer Drugs Market  

    9.1. Japan Thyroid Cancer Drugs Market Overview  

    9.2. Japan Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9.3. Japan Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9.4. Japan Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10. Australia Thyroid Cancer Drugs Market  

    10.1. Australia Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10.2. Australia Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10.3. Australia Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11. Indonesia Thyroid Cancer Drugs Market  

    11.1. Indonesia Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11.2. Indonesia Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11.3. Indonesia Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12. South Korea Thyroid Cancer Drugs Market  

    12.1. South Korea Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12.2. South Korea Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12.3. South Korea Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13. Western Europe Thyroid Cancer Drugs Market  

    13.1. Western Europe Thyroid Cancer Drugs Market Overview

    13.2. Western Europe Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13.3. Western Europe Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13.4. Western Europe Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14. UK Thyroid Cancer Drugs Market  

    14.1. UK Thyroid Cancer Drugs Market Overview

    14.2. UK Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14.3. UK Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14.4. UK Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15. Germany Thyroid Cancer Drugs Market  

    15.1. Germany Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15.2. Germany Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15.3. Germany Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16. France Thyroid Cancer Drugs Market  

    16.5. France Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16.6. France Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16.7. France Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17. Eastern Europe Thyroid Cancer Drugs Market  

    17.1. Eastern Europe Thyroid Cancer Drugs Market Overview

    17.2. Eastern Europe Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17.3. Eastern Europe Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17.4. Eastern Europe Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18. Russia Thyroid Cancer Drugs Market  

    18.1. Russia Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18.2. Russia Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18.3. Russia Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19. North America Thyroid Cancer Drugs Market  

    19.1. North America Thyroid Cancer Drugs Market Overview

    19.2. North America Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19.3. North America Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19.4. North America Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20. USA Thyroid Cancer Drugs Market  

    20.1. USA Thyroid Cancer Drugs Market Overview

    20.2. USA Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20.3. USA Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20.4. USA Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21. South America Thyroid Cancer Drugs Market  

    21.1. South America Thyroid Cancer Drugs Market Overview

    21.2. South America Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21.3. South America Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21.4. South America Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22. Brazil Thyroid Cancer Drugs Market  

    22.1. Brazil Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22.2. Brazil Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22.3. Brazil Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23. Middle East Thyroid Cancer Drugs Market  

    23.1. Middle East Thyroid Cancer Drugs Market Overview

    23.2. Middle East Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23.3. Middle East Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23.4. Middle East Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24. Africa Thyroid Cancer Drugs Market  

    24.1. Africa Thyroid Cancer Drugs Market Overview

    24.2. Africa Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24.3. Africa Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24.4. Africa Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    25. Thyroid Cancer Drugs Market Competitive Landscape And Company Profiles

    25.1. Thyroid Cancer Drugs Market Competitive Landscape

    25.2. Thyroid Cancer Drugs Market Company Profiles

    25.2.1. Mylan Pharmaceuticals Inc.

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Alara Pharmaceutical Corporation

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. Bristol Myers co.

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. Teva parenteral medicines Inc.

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Jerome Stevens Pharmaceuticals Inc.

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Thyroid Cancer Drugs Market

    27. Thyroid Cancer Drugs Market Trends And Strategies

    28. Product Pipeline Analysis

    29. Thyroid Cancer Drugs Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Table 3: Global Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 4: Global Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 5: Global Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 6: Global Thyroid Cancer Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 7: Global Thyroid Cancer Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 10: Asia-Pacific, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 11: China, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 12: China, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 13: China, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 14: India, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 15: India, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 16: India, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 17: Japan, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 18: Japan, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 19: Japan, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 20: Australia, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 21: Australia, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 22: Australia, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 23: Indonesia, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 24: Indonesia, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 25: Indonesia, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 26: South Korea, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 27: South Korea, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 28: South Korea, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 29: Western Europe, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 30: Western Europe, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 31: Western Europe, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 32: UK, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 33: UK, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 34: UK, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 35: Germany, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 36: Germany, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 37: Germany, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 38: France, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 39: France, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 40: France, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 41: Eastern Europe, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 42: Eastern Europe, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 43: Eastern Europe, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 44: Russia, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 45: Russia, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 46: Russia, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 47: North America, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 48: North America, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 49: North America, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 50: USA, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 51: USA, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 52: USA, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 53: South America, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 54: South America, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 55: South America, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 56: Brazil, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 57: Brazil, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 58: Brazil, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 59: Middle East, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 60: Middle East, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 61: Middle East, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 62: Africa, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 63: Africa, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 64: Africa, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 65: Mylan Pharmaceuticals Inc. Financial Performance
  • Table 66: Alara Pharmaceutical Corporation Financial Performance
  • Table 67: Bristol Myers co. Financial Performance
  • Table 68: Teva parenteral medicines Inc. Financial Performance
  • Table 69: Jerome Stevens Pharmaceuticals Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Figure 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Figure 3: Global Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 4: Global Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 5: Global Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 6: Global Thyroid Cancer Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 7: Global Thyroid Cancer Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 10: Asia-Pacific, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 11: China, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 12: China, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 13: China, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 14: India, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 15: India, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 16: India, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 17: Japan, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 18: Japan, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 19: Japan, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 20: Australia, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 21: Australia, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 22: Australia, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 23: Indonesia, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 24: Indonesia, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 25: Indonesia, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 26: South Korea, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 27: South Korea, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 28: South Korea, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 29: Western Europe, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 30: Western Europe, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 31: Western Europe, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 32: UK, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 33: UK, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 34: UK, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 35: Germany, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 36: Germany, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 37: Germany, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 38: France, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 39: France, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 40: France, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 41: Eastern Europe, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 42: Eastern Europe, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 43: Eastern Europe, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 44: Russia, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 45: Russia, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 46: Russia, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 47: North America, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 48: North America, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 49: North America, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 50: USA, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 51: USA, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 52: USA, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 53: South America, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 54: South America, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 55: South America, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 56: Brazil, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 57: Brazil, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 58: Brazil, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 59: Middle East, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 60: Middle East, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 61: Middle East, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 62: Africa, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 63: Africa, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 64: Africa, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 65: Mylan Pharmaceuticals Inc. Financial Performance
  • Figure 66: Alara Pharmaceutical Corporation Financial Performance
  • Figure 67: Bristol Myers co. Financial Performance
  • Figure 68: Teva parenteral medicines Inc. Financial Performance
  • Figure 69: Jerome Stevens Pharmaceuticals Inc. Financial Performance
Research And Development Initiatives Taken In The Anti-Infective Drugs Market
Research Initiatives And Funding And Demand For New Medicines For Drug-Resistant Infections In The Anti-Infective Drugs Industry
Global Biologics Market, Opportunities And Strategies Market | Characteristics, Forecast Size, Trends
Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021
View Report
Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2022
View Report
Cardiovascular Drugs Global Market Report 2019
View Report
Dermatology Drugs Global Market Report 2019
View Report
Gastrointestinal Drugs Global Market Report 2019
View Report
Hematology Drugs Global Market Report 2019
View Report
Metabolic Disorders Drugs Global Market Report 2019
View Report
Musculoskeletal Disorders Drugs Global Market Report 2019
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)